Atlas Trials

Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer

Clinical trial NCT03114631 · COMPLETED

Trial details

NCT number
NCT03114631
Sponsor
The Republican Research and Practical Center for Epidemiology and Microbiology
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Dendritic CellsPancreatic Neoplasms
Start date
2017-01-09
Primary completion
2019-05-03
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.